NCT00044031 2014-04-17Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic CarcinomaCancer Advances Inc.Phase 3 Completed394 enrolled